Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

Saved in:
Bibliographic Details
Title: Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Authors: Åkerblom A; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. Axel.Akerblom@ucr.uu.se.; Uppsala Clinical Research Center, Dag Hammarskjölds väg 38, 751 85, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se., Wojdyla D; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Steg PG; INSERM-Unité 1148, Paris, France.; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France.; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France.; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK., Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden., James SK; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden., Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland., Katus HA; Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany., Himmelmann A; AstraZeneca Research and Development, Mölndal, Sweden., Huber K; Department of Cardiology and Intensive Care Medicine, Wilhelminen Hospital, Vienna, Austria.; Medical School, Sigmund Freud University, Vienna, Austria., Siegbahn A; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden., Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Becker RC; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.; Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH, USA.
Corporate Authors: PLATO Investigators
Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2019 Nov; Vol. 48 (4), pp. 563-569.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first